Key considerations when adopting Droplet Digital PCR for viral vector manufacture

Cell & Gene Therapy Insights 2022; 8(1), 161;

10.18609/cgti.2022.007

Published: 24 February 2022
FastFacts


Increase your knowledge of: 

  • The crucial considerations when transitioning into ddPCR from a different platform. 
  • The additional key areas in which ddPCR is beginning to be applied and the impact made. 
  • The key issues and standardization requirements that are relevant to the various specific applications of ddPCR.

Mark White is the Associate Director of Biopharma Product Marketing at Bio-Rad. He has played a key role in the development of multiple core technology capabilities and assays alongside a multidisciplinary team of biologists and engineers at Bio-Rad and previously at Berkeley Lights Inc.. Mark obtained his Ph.D. in Biomedical Sciences at the University of California, San Francisco.

View pdf




We hope you enjoyed this FastFacts video. You can also view the summary PDF here


Authorship & Conflict of Interest

Contributions: All named authors take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Acknowledgements: None

Disclosure and potential conflicts of interest: The author has no conflicts of interest to disclose. 

Funding declaration: The authors received no financial support for the research, authorship and/or publication of this article. 

Article & copyright information

Copyright: Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Attribution: Copyright © 2022 Bio-Rad Laboratories. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.

Article source: From a FastFacts video recorded on Feb 10 2022; Publication date: Feb 28 2022.


This article is part of the Vectors channel, Enhancing vector bioprocess scalability 2022 edition